Lyell Immunopharma (LYEL) has a market capitalization of $190.2M, based on 287.72M shares at a price of $0.66 (up 4.6% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $0.62 | 19,540,029 | 287,723,827 | $178,043,504.15 |
January 2025 | $0.59 | 16,066,405 | 287,723,827 | $169,843,375.08 |
December 2024 | $0.64 | 28,198,403 | 256,309,000 | $164,037,760.00 |
November 2024 | $0.95 | 29,243,004 | 256,309,000 | $242,237,635.90 |
October 2024 | $0.96 | 34,174,147 | 256,309,000 | $246,133,532.70 |
September 2024 | $1.38 | 16,398,837 | 256,309,000 | $353,706,420.00 |
August 2024 | $1.45 | 14,369,826 | 256,309,000 | $371,648,050.00 |
July 2024 | $1.61 | 14,892,836 | 256,309,000 | $412,657,490.00 |
June 2024 | $1.45 | 30,884,633 | 255,398,000 | $370,327,100.00 |
May 2024 | $2.77 | 15,605,384 | 255,398,000 | $707,452,460.00 |
April 2024 | $2.17 | 20,203,679 | 255,398,000 | $554,213,660.00 |
March 2024 | $2.23 | 17,428,837 | 254,252,000 | $566,981,960.00 |
February 2024 | $2.92 | 18,050,528 | 254,252,000 | $742,415,840.00 |
January 2024 | $1.83 | 25,704,147 | 254,252,000 | $465,281,160.00 |
December 2023 | $1.94 | 34,077,500 | 253,085,800 | $490,986,452.00 |
November 2023 | $1.73 | 24,603,700 | 253,085,800 | $437,838,434.00 |
October 2023 | $1.66 | 15,320,400 | 253,085,800 | $418,856,999.00 |
September 2023 | $1.47 | 16,504,100 | 251,318,000 | $369,437,460.00 |
August 2023 | $2.39 | 14,307,900 | 251,318,000 | $600,650,020.00 |
July 2023 | $2.89 | 13,457,400 | 251,318,000 | $726,309,020.00 |
June 2023 | $3.18 | 31,807,100 | 250,204,000 | $795,648,720.00 |
May 2023 | $3.19 | 24,620,700 | 250,204,000 | $798,150,760.00 |
April 2023 | $2.03 | 17,276,900 | 250,204,000 | $507,914,120.00 |
March 2023 | $2.36 | 27,163,500 | 249,591,000 | $589,034,760.00 |
February 2023 | $2.15 | 15,988,000 | 249,591,000 | $536,620,650.00 |
